VAERS reports by lot

Moderna COVID-19 lot 007821A: VAERS reports

40 VAERS reports list lot 007821A as a Moderna COVID-19 vaccine, received between 2021-03-21 and 2023-04-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
40
Reports
8%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3124%
Neurological2620%
Dermatological (non-injection-site)1411%
Injection-site / Local reaction129%
Respiratory119%
Musculoskeletal119%
Gastrointestinal97%
Allergic / Anaphylactic65%
Cardiac / Cardiovascular43%
Thrombotic / Hematological22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania9
Michigan8
Indiana4
Minnesota3
Texas3
New Jersey3
New York2
Florida2
Vermont1
Missouri1
Maryland1
Ohio1

Reports by month received

2021-037
2021-0412
2021-053
2021-062
2021-0810
2021-122
2022-021
2022-032
2023-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.